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In this issue of the Journal, Ong et al. (1) sought to
determine the prevalence of coronary spasm in angina
patients with angiographically normal coronary arteries. Of
304 patients with stable angina, 144 (47%) had normal
coronary arteries or only minimal irregularities (20%
diameter reduction) at coronary angiography. Acetylcholine
(ACH) testing was performed in 124 of the 144 patients
and provoked coronary spasm in 77 (62%). Thirty-five
patients (45%) with constrictor response presented with
epicardial spasm (defined as a 75% diameter reduction
with reproduction of the symptoms of the patient), and 42
patients (55%) presented with microvascular spasm (defined
as ischemic electrocardiographic changes with symptom
reproduction, but no epicardial spasm). Overall two-thirds
of patients undergoing the ACH test presented with abnor-
mal coronary artery vasomotion, a finding that also con-
firmed the presence of the ischemic syndrome.
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The authors are to be congratulated for attempting to
determine pathophysiological mechanisms underlying
symptoms and evidence of myocardial ischemia in this
patient population. Indeed, in the absence of obstructive
coronary artery disease (CAD), management of patients
with angina represents an unsolved challenge. Such patients
are often labeled as either patients with “atypical angina” or
patients with “false positive results” at noninvasive evalua-
tion. However, long-term follow-up studies suggest that
patients with angina and ischemia, who do not display
obstructive CAD, have increased coronary event rates and
adverse quality of life as compared with those with no
evidence of ischemia (2), underscoring the relevance of
proper identification and treatment.
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opted to invasively assess the coronary endothelial function.
In normal conditions, ACH causes vasodilation by releasing
nitric oxide or closely related substances via endothelial
receptors (3). However, in the presence of endothelial
dysfunction, an early marker of coronary atherosclerosis
(4–6), ACH induces coronary vasoconstriction via recep-
tors localized into the smooth muscle cells (7,8). The degree
of coronary constriction in response to ACH administration
can vary considerably, ranging from mild to complete or
near-complete coronary flow obstruction, as typically ob-
served in patients with variant angina (9) who present with
localized hyper-responsiveness (10). Indeed, as documented
from the first angiography studies (11,12), the “state of the
art” patient with variant angina was the patient with: 1) rest
angina; 2) normal or near coronary artery tree; and 3) complete or
near-complete dynamic focal obstruction at provocative test.
However, the concept of coronary spasm has evolved
since then. The relevance of coronary spasm has been
demonstrated in clinical scenarios other than variant angina
(i.e., stable angina) (13,14), in which involvement of the
coronary microcirculation has been suggested as well (15).
Moreover, it is now accepted that the degree of spasm can
be affected by a number of factors, including resting vaso-
motor tone, segmental epicardial coronary artery hyperac-
tivity, and organic stenosis (16,17).
Ong et al. (1) administered intracoronary ACH in
patients with exertional angina. The test was considered
positive for spasm when either an epicardial coronary flow
reduction of 75% at angiography or ischemic electrocar-
diographic changes occurred during symptom reproduction.
They excluded per-protocol patients with significant coro-
nary atherosclerosis, adhering to the dogma for searching
coronary artery spasm only in patients with normal and
near-normal coronary arteries.
Actually, there is no reason to believe that abnormal
coronary vasomotion and endothelial dysfunction are exclu-
sive to coronary vessels with no or minimal atherosclerosis.
By limiting investigations to this subset of patients, the
relevance of functional factors in precipitating myocardial
ischemia might be underestimated.
Coronary spasm, which was initially demonstrated in
patients with normal or near-normal coronary arteries
(11,12), frequently occurs at sites of significant atheroscle-
rosis, both in acute and chronic settings (18–21). Spasm of
atherosclerotic lesions is often associated with myocardial
ischemia (16,22,23), with coronary vasomotor response
closely related to plaque burden (24). Moreover, normal or
near-normal coronary arteries of patients with focal vaso-
spasms show angiographically insignificant atherosclerosis
(25), suggesting that paradoxical constriction can occur both
during the early as well as advanced stages of disease (26). In
addition, the presence of obstructive CAD does not pre-
clude spasm of adjacent, nonobstructive coronary segments
(27,28), which can actually be responsible for ischemia.
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Coronary Vasospasm and Coronary Atherosclerosis February 14, 2012:663–4Finally, the contribution of coronary vasomotion to precip-
itation of myocardial ischemia has been recently demon-
strated in patients with acute coronary syndrome and
significant atherosclerotic lesions who were administered
intracoronary nitroglycerin (29).
In conclusion, Ong et al. (1) must be congratulated for
stressing the role functional factors in precipitating myocar-
dial ischemia. However, to achieve a more comprehensive
approach to ischemic heart disease, such factors should be
considered also in patients with obvious coronary athero-
sclerosis.
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